NDC 51662-1239-2 - NALOXONE HYDROCHLORIDE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
51662-1239
Requested NDC
51662-1239-2
Package NDCs from labels
51662-1239-1, 51662-1239-2, 51662-1239-3
Manufacturer
HF Acquisition Co. LLC, DBA HealthFirst
Effective date
2024-01-25
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
NALOXONE HYDROCHLORIDE - HF Acquisition Co. LLC, DBA HealthFirstHF Acquisition Co. LLC, DBA HealthFirst2024-01-25HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1239-1NALOXONE HYDROCHLORIDE2 mL in 1 SYRINGE, PLASTICINJECTION26
51662-1239-1NALOXONE HYDROCHLORIDE1 in 1 BOXINJECTION16
51662-1239-2NALOXONE HYDROCHLORIDE1 mL in 1 POUCHINJECTION16
51662-1239-3NALOXONE HYDROCHLORIDE10 in 1 CASEINJECTION106

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1239NALOXONE HYDROCHLORIDE INJECTION [HF ACQUISITION CO. LLC, DBA HEALTHFIRST]6Current NDC, Legacy NDC, 4 package rows20240126_74fc593e-ed47-efae-e053-2991aa0a5997.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 4 of 6 · 102 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Naloxone HydrochlorideNALOXONE HYDROCHLORIDECVS Pharmacy, Inc840e017d-0142-4d0e-a80e-327ac44bc0c52024-04-24WarningsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEWalgreen Co.3829826b-e48f-4e26-869f-6b9e4ee0a8402024-04-24WarningsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONEAmneal Pharmaceuticals NY LLC8779a073-dc6e-410a-9959-fd370f0079f92024-04-19WarningsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEMylan Institutional LLC7faaedb3-227b-408d-b772-6b326638b00e2024-04-12Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEPar Health USA, LLC3ae08e26-223b-4971-b2f1-f1e183a3f9302024-04-11Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
Naloxone HydrochlorideNALXONE HYDROCHLORIDEHikma Pharmaceuticals USA Inc.1bef59b9-7d51-4f19-a054-44b8eb6c63982024-04-10Warnings, Adverse reactionsExact identifier
unii: F850569PQR
naloxone hydrochlorideNALOXONE HYDROCHLORIDELifestar Pharma LLCef647e2a-84e7-4e3e-942a-b6fc250141b62024-03-04Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirstc72a60fb-196d-3f02-e053-2995a90ad9062024-02-22Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
Narcan Naloxone HCLNARCAN NALOXONE HCLHF Acquisition Co LLC, DBA HealthFirst11d770b8-b768-ba3d-e063-6394a90a61a62024-02-20WarningsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirst94ff1857-06da-7986-e053-2a95a90afb182024-02-19Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirstc90e2d85-ed94-2c00-e053-2a95a90ad2a02024-01-30Warnings, Adverse reactionsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDEActavis Pharma, Inc.49350f7e-d613-40a8-8941-a2ec30eafdf32024-01-30WarningsExact identifier
unii: F850569PQR
NALOXONE HClNALOXONE HCLHF Acquisition Co LLC, DBA HealthFirstf8fcda15-8ba6-e66a-e053-6294a90a385c2024-01-28Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HCINALOXONE HCIHF Acquisition Co. LLC, DBA Health First73c1bad3-6ac3-8682-e053-2a91aa0a176a2024-01-27Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co LLC, DBA HealthFirste65e03c1-9a66-b30b-e053-2995a90aeb732024-01-27Warnings, Adverse reactionsExact identifier
rxcui: 1191250
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEHF Acquisition Co. LLC, DBA HealthFirst74fc593e-ed47-efae-e053-2991aa0a59972024-01-25Warnings, Adverse reactionsExact identifier
application number: ANDA072076
ndc (package): 51662-1239-1
ndc (package): 51662-1239-2
ndc (package): 51662-1239-3
ndc (product): 51662-1239
ndc11 (package): 51662123902
rxcui: 1191250
spl id: 0fcaff2c-afb8-788b-e063-6394a90ade78
spl set id: 74fc593e-ed47-efae-e053-2991aa0a5997
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDETeva Pharmaceuticals, Inc.3a73ee4b-c2a4-496f-be90-9f78c80460622024-01-01WarningsExact identifier
unii: F850569PQR
NALOXONE HYDROCHLORIDENALOXONE HYDROCHLORIDEA-S Medication Solutions46f27d04-d4d2-4ef1-9cc5-4d58f4056f062023-12-27WarningsExact identifier
unii: F850569PQR
Naloxone HydrochlorideNALOXONE HYDROCHLORIDE NASALA-S Medication Solutions4517afa1-4b17-4a15-b91b-65b18bd0558f2023-11-24Warnings, Adverse reactionsExact identifier
unii: F850569PQR
NARCAN NALOXONE HCINARCAN NALOXONE HCIHF Acquisition Co LLC, DBA HealthFirst784a0e98-c2d6-f845-e053-2991aa0ac4b42023-10-10Warnings, Adverse reactionsExact identifier
unii: F850569PQR

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.